KOSDAQCosmetics251970

Pum-Tech Korea

₩77,000▲ 0.92%2026-11-18 close
Market Cap
₩954.8B
Turnover
₩6.7B
Volume
90K
Shares out.
12.4M
PER
18.7×
PBR
2.8×
EPS
₩4,075
Dividend Yield
0.59%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩450 per share · Prices as of the 2026-11-18 close

01

Report overview

Indie Demand and Capacity Expansion Drive Profit Recovery

Pum-Tech Korea's revenue and operating profit have risen for three consecutive quarters since the fourth quarter of 2025, and the next checkpoints are the completion of Plant 6 and the 2026 annual report.

  1. 1

    Revenue reached KRW 372 billion in 2025, up 10.2% year on year, and operating profit rose 16.8% to KRW 56.5 billion.

  2. 2

    Net profit attributable to controlling shareholders fell 10.1% to KRW 34.4 billion in 2025, moving in the opposite direction from operating profit.

  3. 3

    Operating profit of KRW 21.7 billion in the second quarter of 2026 and KRW 25.1 billion in the third quarter are the largest quarterly figures in the disclosed period from the third quarter of 2025 to the third quarter of 2026.

  4. 4

    Indie-brand orders and the ramp-up of Plant 4 anchor the recovery, while a slower Plant 4 ramp-up and plastic component shortages weighed on the first quarter of 2026.

  5. 5

    Market capitalization sits well above controlling shareholders' equity at the end of 2025, so the central question is how far the recent earnings recovery can support that premium.

02

Business structure

Pum-Tech Korea is a specialist maker of cosmetic containers, centered on pumps and dispensers, tubes, compacts and sticks. According to a KB Securities analysis cited for 2024, product mix was 41% pump and container products, 23% tube products, 16% compact products and 14% stick products.

By customer, indie brands accounted for 59%, large domestic companies for 13%, overseas customers outside Japan for 23% and Japan for 4%. A high indie-brand share reduces dependence on any single brand but also means the company is directly exposed to shifts in domestic indie trends.

Its tube business is run by a subsidiary in which it holds a 47% stake. In 2023, the two companies' combined market share was 28.28%, the highest in the sector, followed by 24.05% for the second-ranked player and 15.99% for the third-ranked player, according to a December 2024 stock-selection report.

Overseas, the company trades directly with Shiseido in Japan and opened a North American sales office in New York in September 2024.

According to the company's annual report, first-half container exports totaled KRW 35.7 billion, about 17% of total revenue, and indirect exports through domestic ODM and OEM customers are not included in that figure. As of the end of June 2026, the company held 521 patents, utility models and design rights in total.

Because it owns about 5,000 proprietary mold sets and retains design IP on its models, it can sell the same models to multiple customers.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩97.7B₩15.3B15.7%
2025Q4₩77.1B₩8.3B10.8%
2026Q1₩91.8B₩13B14.1%
2026Q2₩116.8B₩21.7B18.5%
2026Q3₩123.8B₩25.1B20.3%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩236.6B₩26.5B₩20B11.2%9.5%23.5%
2023₩284.5B₩35.3B₩29.1B12.4%12.2%23.8%
2024₩337.5B₩48.4B₩38.3B14.3%14.4%27.1%
2025₩372B₩56.5B₩34.4B15.2%11.7%28.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On a disclosed annual basis, revenue rose from KRW 236.6 billion in 2022 to KRW 372 billion in 2025.

Revenue grew to KRW 284.5 billion in 2023 (up 20.2%), KRW 337.5 billion in 2024 (up 18.6%) and KRW 372 billion in 2025 (up 10.2%), rising for three consecutive years from 2023 through 2025, with 2025 the largest year of 2022 to 2025.

Operating profit went from KRW 26.5 billion in 2022 to KRW 35.3 billion, KRW 48.4 billion and KRW 56.5 billion, also rising for three consecutive years, although growth slowed from 33.3% in 2023 and 37.1% in 2024 to 16.8% in 2025.

Operating margin rose from 11.2% in 2022 to 12.4%, 14.3% and 15.2%, so profit growth came alongside margin expansion. Net profit attributable to controlling shareholders, however, peaked at KRW 38.3 billion in 2024, the largest year in the period, before falling 10.1% to KRW 34.4 billion in 2025.

The gap between rising operating profit and falling controlling-shareholder net profit may reflect non-operating items and income taxes, and the specific drivers can be traced in the income statement notes of the annual report.

Operating cash flow rose from KRW 29.4 billion in 2022 to KRW 61.2 billion in 2025, so cash backing for earnings strengthened.

Quarterly, revenue of KRW 97.7 billion and operating profit of KRW 15.3 billion in the third quarter of 2025 fell in the fourth quarter to KRW 77.1 billion (down 21.0% quarter on quarter) and KRW 8.33 billion (down 45.6%).

Controlling-shareholder net profit for the fourth quarter of 2025 is not available in the disclosed data. First-quarter 2026 revenue was KRW 91.8 billion and operating profit KRW 13 billion, as slower Plant 4 ramp-up and plastic component shortages kept production behind orders.

Second-quarter revenue recovered to KRW 116.8 billion (up 27.3% quarter on quarter) and operating profit to KRW 21.7 billion (up 67.0%).

Third-quarter revenue reached KRW 123.8 billion (up 6.0% quarter on quarter and 26.7% year on year) and operating profit KRW 25.1 billion (up 16.1% quarter on quarter and 64.0% year on year).

Controlling-shareholder net profit, however, moved from KRW 18.2 billion to KRW 18.3 billion (up 0.6%), so it lagged operating profit growth.

05

Industry analysis

According to the company's annual report, Korean cosmetics exports in 2025 totaled USD 11.4 billion, up 12% year on year, and the number of export destinations rose from 172 countries in 2024 to 202. Indie-brand demand is closely tied to this trend.

Pump-division sales to indie brands rose from KRW 122.5 billion in 2023 to KRW 146.1 billion in 2024 and KRW 167.9 billion in 2025, according to a June 2026 Money Today report citing research estimates.

In competition, the company and its tube subsidiary held the largest combined share in 2023, with the second- and third-ranked players also holding double-digit shares, making the sector concentrated among a few players.

On the cycle, Hankyung-cited analysis from March 2025 noted that order backlogs stayed high after the second quarter, eliminating the usual third-quarter slowdown. In July 2026, Yuanta Securities said orders continued to exceed production.

On inputs, Meritz Securities reported in May 2026 that PE and PP supply, which had been tight, was easing according to management. Interest from major overseas brands in Korean-made containers is another variable.

According to Money Today, the company began recognizing initial volumes from a project tied to a large overseas customer's brand in the third quarter of 2025. Whether these volumes turn into sustained orders will show up in later results.

06

Outlook

The company is preparing to complete Plant 6 in the second half of 2026, with land investment of about KRW 14.6 billion and building investment of about KRW 9.4 billion reported. A purchase agreement for a Plant 7 site was signed in April 2026, with land investment of KRW 19.6 billion.

Part of Plant 6 is being built as a cleanroom for pharmaceutical and health-functional-food containers, according to a KB Securities report from February 2026. Estimates also exist. In a July 2026 report, Yuanta Securities projected 2026 revenue of KRW 438.8 billion and operating profit of KRW 70 billion.

On June 9, 2026, Research Allum initiated coverage with a fair value of KRW 46,000 and a Positive rating, citing early capacity effects, expanding orders from overseas customers and new pharmaceutical and health-functional-food container businesses. That target reflects the view at the time of publication.

KB Securities had projected 2026 revenue of KRW 450.2 billion and operating profit of KRW 67.7 billion in February 2026, before later results were disclosed. The next test is whether expanded capacity from Plant 6 shows up in quarterly revenue, and whether orders continue to exceed production.

The contribution of overseas customer volumes and the pharmaceutical and health-functional-food container business is not separately disclosed, so it remains a qualitative element.

07

Valuation

PER
18.7×
PBR
2.8×
ROE
14.6%
EPS
₩4,075
BPS
₩27,142
Dividend per share
₩450

Market capitalization stands far above controlling shareholders' equity of KRW 294.5 billion at the end of 2025, a large premium over book value.

Controlling-shareholder net profit over the last four quarters totals KRW 45.9 billion, above the KRW 34.4 billion reported for full-year 2025, so the earnings base used for valuation has shifted from the full year to the most recent four quarters.

Early-2026 broker reports treated the fourth quarter of 2025 as the earnings trough and interpreted multiples on the assumption of quarterly growth in 2026. That assumption has been partly borne out in quarterly results since the first quarter of 2026, though net profit growth has lagged operating profit growth.

Operating cash flow rose from KRW 29.4 billion in 2022 to KRW 61.2 billion in 2025, while the debt ratio climbed from 23.5% to 28.1% over the same period, so capacity investment and working capital have grown alongside borrowings.

Dividend capacity is better judged against cash flow and investment plans than against profit alone. How the valuation reads will depend on how stable earnings become once Plant 6 is running.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Expanding indie-brand demand

Pump-division sales to indie brands rose each year, from KRW 122.5 billion in 2023 to KRW 146.1 billion in 2024 and KRW 167.9 billion in 2025. Indie brands made up 59% of customers in 2024, the core of the customer base. Korean cosmetics exports grew 12% in 2025 to USD 11.4 billion, according to the company's annual report.

Quarterly earnings rebound

Revenue and operating profit have increased for three consecutive quarters since the fourth quarter of 2025 trough. Third-quarter 2026 operating profit of KRW 25.1 billion rose 64.0% year on year. Yuanta Securities said in a July 2026 report that orders continued to exceed production.

Capacity expansion and overseas reach

Plant 4 was completed in November 2025, and Plant 6 is scheduled for completion in the second half of 2026. A Plant 7 site purchase agreement was signed in April 2026. Overseas, the company trades directly with Shiseido in Japan and opened a North American sales office in New York in September 2024.

09

Bear factors

Production disruptions and margin pressure

In the first quarter of 2026, slower Plant 4 ramp-up and a shortage of plastic components left production behind orders. A higher mix of low-priced dropper products and one-off costs tied to capacity expansion added pressure. Operating profit that quarter was KRW 13 billion.

Gap between operating profit and net profit

Operating profit rose 16.8% to KRW 56.5 billion in 2025, while controlling-shareholder net profit fell 10.1% to KRW 34.4 billion. In the third quarter of 2026, operating profit rose 16.1% quarter on quarter, but controlling-shareholder net profit grew only 0.6%. How much of the operating profit gain reaches net profit is a point the next periodic report will show.

Customer concentration and external factors

With indie brands at 59% of customers in 2024, earnings may be sensitive to shifts in domestic indie trends. KB Securities cited tariff effects and a delayed Plant 4 completion approval as factors behind the weak fourth quarter of 2025, in a February 2026 report. The debt ratio rose from 23.5% in 2022 to 28.1% in 2025.

10

Risk factors

Raw materials and supply chain

Plastic inputs such as PE and PP are a key variable for prices and supply. Meritz Securities reported in May 2026 that supply had improved from earlier levels, though it noted differences by grade. A renewed tightening could bring production disruptions and cost pressure together.

Capacity ramp-up risk

The timing of Plant 6 completion and the pace of Plant 4 ramp-up will determine how much added capacity actually contributes. Land investment of KRW 19.6 billion has already been committed to the Plant 7 site. Continued capacity spending could raise debt burdens, so the debt ratio needs to be tracked alongside.

Tariffs and export exposure

Tariff effects were cited for the weak fourth quarter of 2025. Meritz Securities also pointed to lower export revenue as a drag in the first quarter of 2026. Direct exports were about 17% of revenue in the first half, so changes in overseas demand also reach earnings through indirect export channels.

11

What to watch next

  1. By end-2026

    The completion and start-up timing of Plant 6. Whether added capacity shows up in quarterly revenue, and whether the cleanroom line for pharmaceutical and health-functional-food containers begins operating, are the points to track.

  2. Around mid-February 2027

    The preliminary fourth-quarter 2026 results. The key questions are whether revenue and operating profit extend the third-quarter trend, and whether controlling-shareholder net profit growth catches up with operating profit growth.

  3. End of March 2027

    The 2026 annual report. Annual revenue, operating margin, controlling-shareholder net profit, the debt ratio and operating cash flow will be checked against the DART-disclosed figures.

  4. Around May 2027

    The first-quarter 2027 results. The check is whether the normalization of Plant 4 and the start of Plant 6 show up in quarterly revenue and operating margin.

12

Overall view

Pum-Tech Korea's disclosed results show revenue and operating profit rising for three consecutive years from 2023 through 2025, with operating margin climbing from 11.2% in 2022 to 15.2% in 2025.

Controlling-shareholder net profit, however, fell 10.1% to KRW 34.4 billion in 2025, so whether operating profit gains carry through to net profit still needs to be verified.

After a first-quarter 2026 trough, operating profit recovered sharply in the second and third quarters, reaching KRW 25.1 billion in the third quarter.

Strengths include indie-brand demand, export growth and capacity expansion including Plant 6, while weaknesses include production disruptions, a less favorable product mix, stalled controlling-shareholder net profit and customer concentration.

With market capitalization well above controlling shareholders' equity, the durability of the earnings recovery is the central issue. The next checkpoints are the completion of Plant 6, the preliminary fourth-quarter 2026 results and the 2026 annual report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 14 more articles and sources
  1. digitaltoday.co.kr
  2. bloter.net
  3. newsquest.co.kr
  4. eureka.hankyung.com
  5. vegannews.co.kr
  6. mt.co.kr
  7. m.thinkpool.com
  8. m.thebell.co.kr
  9. buffettlab.co.kr
  10. investing.com
  11. ket.kr
  12. hankyung.com
  13. m.news.nate.com
  14. dailyinvest.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis